Clinical Trials · NCT02053779

GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Centre Hospitalier Universitaire Ibn Rochd
Enrollment
328
Start date
Mar 2014
Locations
1 site, Algeria
Primary endpoint
implantation rate
View Gonadorelin compound reference